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Invirsa Agreement Allows Student to Conduct Preclinical Drug Testing 
 
CEDARVILLE, OHIO -- Cedarville University’s School of Pharmacy and Invirsa Inc. of Columbus 
are partnering on testing lead compounds for enhancing the innate human immune system. This 
work may help reduce topical viral infections while supporting the body’s wound healing 
response. 
  
Olivia Van Wyck, a third-year professional pharmacy student from Jericho, Vermont, is working 
with Dr. Rocco Rotello, associate professor of pharmaceutical sciences, on this research 
initiative. The research data will be used to validate the compound's effect in the preclinical 
stage so that animal and human testing may ultimately occur. 
  
This preclinical testing should be completed by the end of June. Van Wyck will then present the 
results to Invirsa. Depending on the initial results, Rotello will continue on the project to further 
test the compound with another proprietary compound to get to the right mixture and 
formulation. 
  
“This experience will help Olivia appreciate the preclinical work that goes into bringing a drug to 
humans,” explained Rotello. “The testing demonstrates all of the upstream discovery work that 
brings a drug into the market.” 
  
“Cedarville has prepared me very well for this experience,” expressed Van Wyck. “Through my 
undergraduate biology and chemistry classes, I received great experience in the lab portion of 
each class. Now, my graduate school learning has given me an understanding of the drug 
research process and how drugs interact with the body.” 
  
Located in southwest Ohio, Cedarville University is an accredited, Christ-centered, Baptist 
institution with an enrollment of 4,193 undergraduate, graduate and online students in more 
than 150 areas of study. Founded in 1887, Cedarville is recognized nationally for its authentic 
Christian community, rigorous academic programs, strong graduation and retention rates, 
accredited professional and health science offerings and leading student satisfaction ratings. 
For more information about the University, visit www.cedarville.edu. 
 
